Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
PUT
Titan Machinery
TITN
$431M
| $389K | ﹤0.01% |
25,100
+24,100
| +2,410% | +$381K |
|
|
TBRG
4402
DELISTED
TruBridge
TBRG
| $389K | ﹤0.01% |
14,467
+6,399
| +79% | +$187K |
|
|
REV
4403
PUT
DELISTED
Revlon, Inc.
REV
| $388K | ﹤0.01% |
17,400
+14,900
| +596% | +$282K |
|
4404
CALL
Trimble
TRMB
$13.4B
| $387K | ﹤0.01% |
8,900
-8,300
| -48% | -$324K |
|
4405
Horizon Bancorp
HBNC
$1.05B
| $386K | ﹤0.01% |
19,569
+10,075
| +106% | +$207K |
|
|
JCAP
4406
DELISTED
Jernigan Capital, Inc.
JCAP
| $386K | ﹤0.01% |
19,983
+5,994
| +43% | +$114K |
|
|
MRNS
4407
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $385K | ﹤0.01% |
9,639
-2,125
| -18% | -$60.5K |
|
|
CBIO
4408
Crescent Biopharma
CBIO
$610M
| $384K | ﹤0.01% |
267
-5
| -2% | -$7.56K |
|
4409
PUT
KeyCorp
KEY
$24.5B
| $384K | ﹤0.01% |
19,300
-5,500
| -22% | -$114K |
|
4410
CALL
VeriSign
VRSN
$25.6B
| $384K | ﹤0.01% |
2,400
-8,400
| -78% | -$1.29M |
|
|
SPWR
4411
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
| $384K | ﹤0.01% |
80,320
-150,562
| -65% | -$713K |
|
|
GPOR
4412
PUT
DELISTED
Gulfport Energy Corp.
GPOR
| $384K | ﹤0.01% |
36,900
+31,200
| +547% | +$358K |
|
4413
PUT
Kinross Gold
KGC
$32.6B
| $383K | ﹤0.01% |
142,000
+19,000
| +15% | +$61.5K |
|
|
GMS
4414
DELISTED
GMS Inc
GMS
| $382K | ﹤0.01% |
16,456
+3,959
| +32% | +$100K |
|
4415
Columbus McKinnon
CMCO
$550M
| $381K | ﹤0.01% |
9,641
+6,512
| +208% | +$272K |
|
|
ESPR
4416
DELISTED
Esperion Therapeutics
ESPR
| $381K | ﹤0.01% |
8,578
+2,491
| +41% | +$114K |
|
4417
CALL
iShares Core S&P 500 ETF
IVV
$910B
| $381K | ﹤0.01% |
1,300
-7,200
| -85% | -$2.07M |
|
4418
CALL
Tower Semiconductor
TSEM
$28.6B
| $381K | ﹤0.01% |
17,500
-19,700
| -53% | -$421K |
|
|
ARDC
4419
Are Dynamic Credit Allocation Fund
ARDC
$298M
| $380K | ﹤0.01% |
24,457
| – | – |
|
4420
Standard BioTools
LAB
$312M
| $380K | ﹤0.01% |
50,680
+47,250
| +1,378% | +$336K |
|
4421
Astrana Health
ASTH
$1.78B
| $378K | ﹤0.01% |
17,120
+15,246
| +814% | +$321K |
|
|
ECOM
4422
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $378K | ﹤0.01% |
30,336
+28,435
| +1,496% | +$378K |
|
4423
CALL
AptarGroup
ATR
$8.43B
| $377K | ﹤0.01% |
3,500
| – | – |
|
4424
PUT
Genesco
GCO
$391M
| $377K | ﹤0.01% |
8,000
-16,700
| -68% | -$729K |
|
4425
CALL
International Flavors & Fragrances
IFF
$21.4B
| $376K | ﹤0.01% |
+2,700
| New | +$355K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.